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Abstract
Polymyalgia rheumatica (PMR) is a relatively frequent disease affecting individuals older than 50 years and is character-
ized by inflammatory involvement of the shoulder and hip girdles and the neck. Clinical manifestations are represented by 
pain and morning stiffness in this regions. An extensive and comprehensive assessment of the inflammatory status is crucial in 
PMR patients, including imaging evaluation. This narrative review reports the current available data in the literature about the 
role of musculoskeletal ultrasound in PMR.
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Introduction
Polymyalgia rheumatica (PMR) is an inflammatory 
rheumatic condition that typically affects individuals old-
er than 50 years, with incidence increasing with age. An 
Italian epidemiologic study reported an annual incidence 
rate of PMR over the period 1980–1988 of 12.7/100,000 
[1-2]. The etiology of PMR remains unknown, although 
currently the role of both genetic and environmental fac-
tors, such as infections, has been hypothesized. Familiar 
aggregation has been described and genetic polymor-
phisms in human leukocyte antigen (HLA) genes and 
other genes in the field of immune regulation have been 
associated with PMR [3-6]. However, to date, no etio-
logic theory has been confirmed.
PMR is more frequent in caucasian population and is 
considered the second most common inflammatory rheu-
matic condition in the United States. The prevalence of 
the disease shows a North-South gradient, with a higher 
incidence in Northern than in Southern countries, includ-
ing Italy [2]. Focusing on the clinical manifestations, 
PMR is characterized by pain and morning stiffness, 
longer than 45 min, involving the neck and the shoulder 
and hip girdles. Stiffness and pain are usually bilateral, 
worsen in the morning and improve with activity. Fa-
tigue, malaise, anorexia, weight loss and fever are also 
common and are considered “constitutional symptoms”. 
An association between PMR and giant-cell arteritis 
(GCA) has been described and PMR has been identified 
in 40-60% of patients affected by GCA; on the contra-
ry, GCA has been registered in 16-21% of patients with 
PMR [7].
An extensive and comprehensive assessment of the 
inflammatory status is crucial in PMR patients, including 
imaging evaluation. Musculoskeletal ultrasonography 
(MSUS) has acquired an increasing role over the recent 
years in the assessment and monitoring of rheumatic 
diseases. In fact, thanks to the progressive technological 
advances and the application of standardized scanning 
techniques and definitions of US pathology, its diagnos-
tic capability has progressively increased [8]. MSUS is a 
multiplanar and dynamic imaging modality with several 
advantages: it is safe, feasible, relatively inexpensive and 
highly accepted by patients. The use of conventional B-
mode US provides a wide set of information about the 
status of different musculoskeletal tissues. In addition, 
the development of power Doppler (PD) and color Dop-
pler (CD) techniques has enhanced the abilities of US 
to detect and evaluate inflammatory joint activity [9]. 
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Fig 1. Distribution of the frequency of SAD bursitis (A) and 
LBT tenosynovitis (B) in the studies analyzed. 
This narrative review focuses on the analysis of currently 
available data in the literature about the role of MSUS in 
the assessment of patients affected by PMR.
Ultrasonography and PMR
In order to perform a comprehensive sonographic 
assessment of girdles in PMR patients, US examina-
tion should be focused on the evaluation of both intra-
articular and extra-articular abnormalities, according to 
a standardized scanning method and published reference 
values [10-11]. 
At shoulder level, the most relevant inflammatory 
findings that should be investigated by US are repre-
sented by gleno-humeral synovitis, subacromial/subdel-
toid (SAD) bursitis, and long-head-biceps tenosynovitis. 
Similarly to the shoulder, MSUS has a key role also in 
the assessment of the hip joint where the presence of syn-
ovitis can be demonstrated as well as the inflammatory 
involvement of local synovial structures (trochanteric, 
iliopsoas, and ischiogluteal bursae).
Ultrasonographic findings in PMR patients  
In the last years, a number of studies have been per-
formed to test the value of MSUS in detecting inflamma-
tory lesions in PMR. As shown in table I, most of them 
were cross-sectional studies, were performed in Southern 
European countries (above all Italy) and described the 
main inflammatory US lesions at disease onset or during 
relapse. Except for the study of Zaccaria et al, they were 
conducted in small groups of PMR patients [12-28]. In 
terms of clinical assessment, when patients were inves-
tigated for the presence of symptoms, shoulder pain was 
the most frequent complain. In some cases, clinimetric 
tests (such as Visual Analogue Scale for pain, patient and 
medical global assessment, Health Assessment Question-
naire, and Leeb’s Disease Activity Score) were also ap-
plied [18-20]. 
In terms of US assessment, all studies were conducted 
by using B-mode US and in two cases PD was addition-
ally applied [19-21] . The shoulder was studied almost in 
all reports while the hip was assessed in few cases. An 
extensive polyarticular US examination was performed 
in two studies which were focused on the comparison be-
tween PMR and Rheumatoid arthritis (RA) [21-22]. Con-
cerning the scoring system used for grading the severity 
of inflammatory lesions, in the majority of studies exclu-
sively a binary assessment was applied [12,13,19,22-24]; 
in a few of them a semiquantitative 0 to 3 score was used 
[18, 25,26], and finally, in two cases both scoring meth-
ods were applied [21-27]. 
The most frequent US abnormalities were detected at 
shoulder level and were represented by SAD bursitis and 
LTB tenosynovitis that have been reported in percent-
ages ranging from 6.2%-100% (fig 1) [12-13]. However, 
the prevalence of SAD bursitis resulted higher compared 
to LBT tenosynovitis in the majority of the studies, sug-
gesting this lesion as the inflammatory hallmark in PMR 
[13,18-20,22,25,26]. Moreover, as reported in Table I, a 
frequent US finding was the identification of bilateral in-
volvement both at shoulder and hip level [19,21,25-27].
In terms of structures involved, the presence of SAD 
bursitis and LTB tenosynovitis was described as the most 
common finding in PMR patients, with a significant 
higher prevalence compared with RA subjects [13]. 
As shown in table I, few reports were conducted ex-
clusively at hip level and, similarly to the shoulder as-
sessments, extra-articular involvement was the most rel-
evant finding with the evidence of trochanteric bursitis 
that was present in a significantly higher number of cases 
with PMR than in controls [27].
In terms of sensitivity two studies from the same re-
search group comparing US to Magnetic Resonance Imag-
ing (MRI) demonstrated that, at shoulder level, US-detect-
ed SAD bursitis was present in 96% of patients and that 
finding was confirmed in 100% of those individuals who 
underwent also MRI assessment [25]. At hip level, a sensi-
tivity and specificity of 100% for US in detecting trochan-
teric bursitis, compared to MRI has been reported [27]. 
Concerning sensitivity to change, table II summarizes 
data obtained from the only three longitudinal studies re-
ported in the literature, in which PMR patients underwent 
an US assessment at baseline and after starting treatment 
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Table I. Cross-sectional studies performed to test the value of MSUS in detecting inflammatory lesions in PMR
Study Country N. of patients
US
scoring system
Power
Doppler
Joints
evaluated US results
Lange  
et al, 
1998
Germany 13 Dichotomic score * No Shoulders GH synovitis: 61.5%
Coari  
et al, 
1999
Italy 16 Dichotomic score * No Shoulders GH effusion: 65.6%
SAD bursitis: 6.2%
LBT tenosynovitis 6.2% 
Lange  
et al, 
2000
Germany 22 Dichotomic score * No Shoulders GH synovitis:  40.9 %
Cantini 
et al, 
2001
Italy 57 Semiquantitative score 
(0-3)
No Shoulders GH synovitis: 77% (bilateral 45%)
SAD bursitis: 96% (bilateral 96%)  
LBT tenosynovitis: 80% (bilateral 72%)
Frediani 
et al, 
2002
Italy 50 Dichotomic score * No Shoulders, hips, 
ankles, wrists, 
elbows, knees, 
hands, feet
GH effusion: 66%
SAD bursitis: 70%
 LBT tenosynovitis: 68% 
Cantini  
et al, 
2005
Italy 20 Dichotomic score *
Bursitis: Semiquantita-
tive-score (0-3)
No Hips CF synovitis: 45%
trochanteric bursitis: 100% (bilateral 90%) 
Catanoso 
et al, 
2007
Italy 6 Semiquantitative-score 
(0-3)
No Shoulders GH synovitis: 33.3%
SAD bursitis: 100%
 LBT tenosynovitis: 100%
Zaccaria 
et al, 
2009
Italy 111 Semiquantitative score 
(0-3)
No Shoulders GH synovitis: 52%
SAD bursitis: 92% (bilateral)
LBT tenosynovitis: 45% (bilateral 34%)  
Macchioni  
et al, 
2009
Italy 57 Dichotomic score * Yes° Shoulders GH synovitis: 15.8 % (bilateral)
SAD bursitis: 61.4 % (bilateral)  
PD in SAD bursitis: 33%
LBT tenosynovitis: 71.9 % (bilateral)
Jimenez-
Palop  
et al, 
2009
Spain 53 Dichotomic score * No Shoulders, hips GH synovitis: 18% 
SAD bursitis:65% 
LBT tenosynovitis: 45%
CF synovitis: 30%
Falsetti et 
al, 2011
Italy 29 All structures: dichoto-
mic score *
PDUS: semiquantita-
tive score (0-4)
Yes Hips, shoulders, 
elbows, wrists, 
MCPs, knees, 
MTPs
GH synovitis: 65.5% (bilateral 73.6%)
SAD bursitis: 79.3% (bilateral 86.9%) 
LBT tenosynovitis: 79.3% (bilateral 78.2%)
 shoulder PDUS score > 0: 6.8%
CF synovitis: 24.1% (bilateral 100%)
Ruta  
et al, 
2012
Argentina 30 Dichotomic score * No Shoulders GH synovitis 11.7%
SAD bursitis: 55%
LBT tenosynovitis: 46.6%
VAS = visual analog scale; MS = morning stiffness; HAQ = health assessment questionnaire; ESR = erythrocyte sedimentation rate; CRP = 
C-reactive protein; SAD = subacromial-deltoidea; LBT = long biceps tendon; GH = gleno-humeral; CF = coxo-femoral; PD = power Dop-
pler; °in 24 patients; *presence/absence
Table II. Prospective studies performed to test the value of MSUS in detecting inflammatory lesions in PMR. 
Study Country N Joints evaluated Treatment Follow-up Us results at follow-up
Catanoso et al.
2007
Italy 6 Shoulders Etanercept 50 mg/week 24 weeks 50% decrease of inflam-
matory lesions 
Macchioni et al.
2009
Italy 57 Shoulders Prednisone (starting dose 
range 12.5-17.5 mg/day)
24 +/- 3 weeks More than 50% decrease 
of inflammatory lesions
Jimenez-Palop et al.
2009
Spain 53 Shoulders hips Prednisone (starting dose 
range 10-20 mg/day)
12 weeks Normal in 50% of patients 
with lesions at baseline
GH = gleno-humeral SAD = subacromial-deltoidea; LBT = long biceps tendon; GH = gleno-humeral; CF = coxo-femoral; PD = power 
Doppler
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for the disease [18-20]. Two studies, published in 2009, 
evaluated the modification of US features in more than 
50 PMR patients, after 12 weeks [20] and 24 weeks [19] 
of treatement with glucocorticoids (prednisone). In both 
studies the therapy with steroids determined a significant 
decrease of the prevalence of inflammatory US features. 
Interestingly, the study published by Jimenez-Palop et al 
identified a significant improvement in US inflammatory 
lesions since week 4.  
Previously, Catanoso et al in 2007 evaluated the re-
sponse to Etanercept treatment in 6 PMR patients re-
fractory to steroid therapy by using US assessment [18]. 
After 12 weeks of treatment, a 50% decrease in the 
prevalence of US features was registered in the enrolled 
patients, suggesting the possible positive effects of anti-
Tumor Necrosis Factor drugs to treat PMR patients. This 
result underlined also the relevant role of US to demon-
strate the efficacy of non-conventional treatment in PMR 
patients. 
Concerning reproducibility, only one study assessed 
the intraobserver and interobserver reliability of US as-
sessment in PMR patients, and demonstrated excellent 
results (k values 0.96 and 0.99, respectively) for both as-
sessments [20]. However, the assessment was performed 
only on stored images and not on real-time US scanning 
thus limiting the reliability assessment to the interpreta-
tion of findings. 
Three studies analyzed the correlations between US 
inflammatory findings and laboratory data [19,20,26]. 
No significant correlations between disease activity bio-
markers and US findings were identified by Macchioni et 
al: in particular, at the evaluation performed at 24 weeks 
follow-up, 59.1% of patients in clinical remission or with 
low disease activity (Leeb’s DAS < 7) showed persistent 
inflammatory lesions at the US evaluation [19]. Moreo-
ver, the studies conducted by Zaccaria et al and Jimenez 
et al in 2009 identified the absence of significant differ-
ences in the US pattern in patients with normal or high 
erythrocyte sedimentation rate (ESR). In addition, even 
in the presence of a parallel decrease in the findings, 
the authors did not find significant correlation between 
changes of clinical, laboratory and US parameters during 
the follow-up period [20,26]. 
In terms of predictive role of US in PMR patients, 
sonographic findings seem not able to predict the occur-
rence of disease relapses [19].
Currently available data suggest a relevant role of 
US as a diagnostic tool for PMR especially in the dif-
ferential diagnosis with other rheumatic conditions with 
a possible polymyalgic onset and in the patients with-
out typical laboratory abnormalities, such as increase of 
ESR. It is well known that PMR can mimic many other 
conditions, resulting in a difficult diagnosis and in the 
under-evaluation of serious diseases, such as tumors, in-
fections, erosive arthritis. According with data from the 
literature, a shift in the diagnosis has been registered in 
5-23% of patients complaining polymyalgic symptoms 
after a follow-up period of 12 months [14,15,28].
Falsetti et al in 2011 demonstrated an improvement 
of diagnostic sensitivity for PMR when US assessment 
was used, especially with the application of PD func-
tion. Sixty-one consecutive patients with clinical typical 
features of PMR underwent multi-district US evaluation 
at baseline and every three months. After a 12-months 
follow-up, a different diagnosis was made in half of pa-
tients (52%): specifically, they met classification crite-
ria for elderly-onset rheumatoid arthritis, elderly onset 
spondyloarthritis, and calcium pyrophosphate deposition 
disease. The authors suggested a predictive model of US 
evaluation to classify PMR patients, including the pres-
ence  of SAD bursitis, low frequency of wrist, metacar-
pophalangeal and metatarsophalangeal effusion/synovi-
tis, low frequency of Achilles enthesitis, low frequency 
of knee menisci chondrocalcinosis, and tendinous cal-
caneal calcifications, and low hypervascularization at 
PDUS analysis in the wrist [19].
Morever, a percentage of PMR patients, ranging 
from 10 to 15% is reported as having a normal ESR. 
The study conducted by Zaccaria in 2009 analyzed this 
specific subset of patients, comparing them to typical 
PMR. No significant differences were described in the 
two groups of patients, concluding that US findings may 
help in the diagnosis of PMR more than laboratory fea-
tures [26]. 
The primary role of US in the diagnosis of PMR pa-
tients determined the inclusion of this imaging tool in 
the new classification criteria, proposed by American 
College of Rheumatology (ACR) and European League 
Against Rheumatism (EULAR) in 2012 [16]. According 
to those criteria, US findings of bilateral shoulder abnor-
malities (SAD bursitis/LTB tenosynovitis/GH effusion) 
or abnormalities in one shoulder and hip (hip effusion, 
trochanteric bursitis) may significantly improve the spec-
ificity of the clinical criteria. Preliminary to the defini-
tion of the last classification criteria, some of the experts 
participating in the study assessed the inter-observer reli-
ability in evaluating   shoulders and hips abnormalities in 
PMR patients [16]. 
Conclusions
This narrative review confirms that MSUS is able to 
identify an extensive inflammatory involvement of extra-
articular synovial structures in PMR patients. According 
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to data described in the literature, the presence of a typi-
cal MSUS pattern in PMR can be identified: the shoulder 
seems to be the most affected site, showing US lesions 
in a higher percentage compared with others rheumatic 
conditions and with healthy controls; SAD bursitis, espe-
cially when bilaterally, appeared to be the US lesion with 
the best diagnostic accuracy, followed by the presence 
of LTB tenosynovitis. Pelvic girdle is less frequently in-
volved, with hip synovitis and trocanteric bursitis being 
the most relevant US lesions reported. 
Generally, the depiction of bilateral abnormalities in 
both girdles achieves high specificity, but has low sensi-
tivity. The presence of positive PD has been frequently 
reported, although this aspect has been investigated only 
in a few studies. 
In order to improve the diagnostic accuracy, as re-
ported in the recent classification criteria, US evaluation 
of shoulder and pelvic girdles is recommended in all pa-
tients with suspected PMR [27]. 
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